Related references
Note: Only part of the references are listed.Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
Perry Stambolsky et al.
CANCER CELL (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo
I. Lambertz et al.
CELL DEATH AND DIFFERENTIATION (2010)
Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function
Aymone Gurtner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro
Manuela Quintavalle et al.
JOURNAL OF CELL BIOLOGY (2010)
Many New Down- and Up-Regulatory Signaling Pathways, From Known Cancer Progression Suppressors to Matrix Metalloproteinases, Differ Widely in Cells of Various Cancers
Gregory S. Delassus et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
Rachel Sarig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma
Brendan Doyle et al.
JOURNAL OF PATHOLOGY (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
A common gain of function of p53 cancer mutants in inducing genetic instability
D. P. Liu et al.
ONCOGENE (2010)
Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models
Carmen Blanco-Aparicio et al.
PLOS ONE (2010)
The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex
Lakshmanane Boominathan
PLOS ONE (2010)
The RhoA GEF Syx Is a Target of Rnd3 and Regulated via a Raf1-Like Ubiquitin-Related Domain
Liuh Ling Goh et al.
PLOS ONE (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
G. Grelier et al.
BRITISH JOURNAL OF CANCER (2009)
Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion
Narendra V. Sankpal et al.
CANCER RESEARCH (2009)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno et al.
CELL (2009)
Rho-GTPase signaling drives melanoma cell plasticity
Victoria Sanz-Moreno et al.
CELL CYCLE (2009)
Dicer1 functions as a haploinsufficient tumor suppressor
Madhu S. Kumar et al.
GENES & DEVELOPMENT (2009)
LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma
Bei Wang et al.
JOURNAL OF HEPATOLOGY (2009)
A Novel Function for p53: Regulation of Growth Cone Motility through Interaction with Rho Kinase
Qingyu Qin et al.
JOURNAL OF NEUROSCIENCE (2009)
p53 Suppresses Src-Induced Podosome and Rosette Formation and Cellular Invasiveness through the Upregulation of Caldesmon
Utpal K. Mukhopadhyay et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway
Peixin Dong et al.
MOLECULAR CANCER (2009)
TAp63 induces senescence and suppresses tumorigenesis in vivo
Xuecui Guo et al.
NATURE CELL BIOLOGY (2009)
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
Shu-Ping Wang et al.
NATURE CELL BIOLOGY (2009)
Integrins: masters and slaves of endocytic transport
Patrick T. Caswell et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Deregulating EMT and senescence: Double impact by a single twist
Marjon A. Smit et al.
CANCER CELL (2008)
p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck
Xiaolian Gu et al.
CANCER LETTERS (2008)
Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2
Gopal Dhar et al.
CANCER RESEARCH (2008)
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy
Gianluca Bossi et al.
CELL CYCLE (2008)
Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments
Patrick T. Caswell et al.
JOURNAL OF CELL BIOLOGY (2008)
Imaging amoeboid cancer cell motility in vivo
S. Pinner et al.
JOURNAL OF MICROSCOPY (2008)
Mammalian Rho GTPases:: new insights into their functions from in vivo studies
Sarah J. Heasman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Twist and p53 reciprocally regulate target genes via direct interaction
M. Shiota et al.
ONCOGENE (2008)
Mutant p53 R270H gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis
Christina Heinlein et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Mutant p53 attenuates the SMAD-dependent transforming growth factor β1 (TGF-β1) signaling pathway by repressing the expression of TGF-β receptor type II
Eyal Kalo et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices
Gilles Gadea et al.
JOURNAL OF CELL BIOLOGY (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Y. Li et al.
ONCOGENE (2007)
Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility
Mingxuan Xia et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinases
Karine Lefort et al.
GENES & DEVELOPMENT (2007)
TAp63 and ΔNp63 in cancer and epidermal development
Eleonora Candi et al.
CELL CYCLE (2007)
Slug is overexpressed in gastric carcinomas and may act synergistically with SIPI and Snail in the down-regulation of E-cadherin
C. Castro Alves et al.
JOURNAL OF PATHOLOGY (2007)
被撤回的出版物: RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress (Retracted article. See vol. 29, pg. 2107, 2019)
Pat P. Ongusaha et al.
CURRENT BIOLOGY (2006)
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
Patrick W. B. Derksen et al.
CANCER CELL (2006)
Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis
Christopher E. Barbieri et al.
CANCER RESEARCH (2006)
Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells
Shinji Mizuarai et al.
CANCER RESEARCH (2006)
p63 regulates an adhesion programme and cell survival in epithelial cells
Danielle K. Carroll et al.
NATURE CELL BIOLOGY (2006)
The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles
Thomas Andl et al.
CURRENT BIOLOGY (2006)
Control of cell migration: a tumour suppressor function for p53?
L Roger et al.
BIOLOGY OF THE CELL (2006)
Transforming growth factor-beta in cancer and metastasis
Sonia B. Jakowlew
CANCER AND METASTASIS REVIEWS (2006)
Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
JY Shih et al.
CLINICAL CANCER RESEARCH (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Tumor predisposition in mice mutant for p63 and p73:: Evidence for broader tumor suppressor functions for the p53 family
ER Flores et al.
CANCER CELL (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion
FK Guo et al.
ONCOGENE (2004)
Expression of p63 TA and △N isoforms) in human primary well differentiated buccal carcinomas
YK Chen et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)
被撤回的出版物: Transactivation of the EGR1 gene contributes to mutant p53 gain of function (Retracted article. See vol. 79, pg. 2085, 2019)
L Weisz et al.
CANCER RESEARCH (2004)
Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis
E Sahai et al.
NATURE CELL BIOLOGY (2003)
Tumor suppressor p53 and its homologue p73α affect cell migration
AA Sablina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rnd proteins function as RhoA antagonists by activating p190 RhoGAP
K Wennerberg et al.
CURRENT BIOLOGY (2003)
P19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities
FK Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients
E Rahko et al.
EUROPEAN JOURNAL OF CANCER (2003)
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors
V Bolós et al.
JOURNAL OF CELL SCIENCE (2003)
Loss of p63 expression is associated with tumor progression in bladder cancer
MJ Urist et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Physical interaction with human tumor-derived p53 mutants inhibits p63 activities
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of Cdc42-mediated morpholigical effects:: a novel function for p53
G Gadéa et al.
EMBO JOURNAL (2002)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis
D Matas et al.
EMBO JOURNAL (2001)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization
A Alexandrova et al.
ONCOGENE (2000)
Physical and functional interaction between p53 mutants and different isoforms of p73
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription
JY Zhao et al.
GENES & DEVELOPMENT (2000)
High metastatic potential in mice inheriting a targeted p53 missense mutation
G Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
